Rituximab,Temelimab
GeNeuro,Biogen,Roche
['imab ', '$gnro', 'geneuro']
geneuro $gnro s protect-ms phase 2 trial data, presented at the ectrims 2022 congress in amsterdam, confirms synergistic neuroprotective potential of temelimab in ms - 
Business Intelligence on European listed biotech companies